Characteristic pattern of chromosomal gains and losses in merkel cell carcinoma detected by comparative genomic hybridization

Cancer Research

Volumn 58, Issue 7, 1998, Pages 1503-1508

  Van Gele, Mireille ^a   Speleman, Frank ^a   Vandesompele, Jo ^a   Van Roy, Nadine ^a   Leonard, J Helen ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Queensland Radium Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 10; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME 8P; CHROMOSOME LOSS; HUMAN; HUMAN CELL; MERKEL CELL; PRIORITY JOURNAL; SKIN CARCINOMA;

CARCINOMA, MERKEL CELL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; HUMANS; MALE; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032054737     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Leonard, J. H. Biology of Merkel cell carcinoma (Thesis). Brisbane, Queensland, Australia: University of Queensland, 1997.
2. Gould, V. E., Moll, R., Moll, I., Lee, I., and Franke, W. W. Biology of disease, neuroendocrine (Merkel) cells of the skin: hyperplasias, dysplasias and neoplasms. Lab. Invest., 52: 334-353, 1985.
3. Meeuwissen, J. A., Bourne, R. G., and Kearsley, J. H. Radiation therapy in the treatment of Merkel cell carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 15: 325-331, 1995.
4. Kusyk, C. J., and Romsdahl, M. M. Cytogenetic study of a Merkel cell carcinoma. Cancer Genet. Cytogenet., 20: 311-316, 1986.
5. Hopfner, C., Teyssier, J. R., Eychenne, D., Lesaunier, F., Nollez, F., and Adnet, J. J. Tumeur neuroendocrine de la peau. Mise en évidence d'anomalies chromosomiques dans les cellules tumorales. Presse Med, 16: 731, 1987.
6. Rosen, S. T., Gould, V. E., Salwen, H. R., Herst, C. V., Le Beau, M. M., Lee, I., Bauer, K., Marder, R. J., Andersen, R., Kies, M. S., Moll, R., Franke, W. W., and Radosevich, J. A. Establishment, and characterization of a neuroendocrine skin carcinoma cell line. Lab. Invest., 56. 302-312, 1987.
7. Sozzi, G., Bertoglio, M. G., Pilotti, S., Rilke, F., Pierotti, M. A., and Porta, G. D. Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma. Cancer Genet. Cytogenet., 30: 151-158, 1988.
8. Sandbrick, F., Müller, L., Fiebig, H. H., and Kovacs, G. Short communication: deletion 7q, trisomy 6 and 11 in a case of Merkel cell carcinoma. Cancer Genet. Cytogenet., 33: 305-309: 1988.
9. Shabtai, F., Sternberg, A., Klar, D., Reiss, R., and Halbrecht, I. Involvement of chromosome 22 in a Merkel cell carcinoma in a patient with previous meningioma. Cancer Genet. Cytogenet., 38: 43-48: 1989.
10. Koduru, P. R., Dicostanzo, D. P., Jhanwar S. C. Non random cytogenetic changes characterize Merkel cell carcinoma. Dis. Markers, 7: 153-161, 1989.
11. Smadja, N., de Gramont, A., Gonzalez-Canali, G., Louvet, C., Wattel, E., and Krulik, M. Cytogenetic study in a bone marrow metastatic Merkel cell carcinoma. Cancer Genet. Cytogenet., 51: 85-87, 1991.
12. Leonard, J. H., Leonard, P., and Kearsley, J. H. Chromosomes 1, 11 and 13 are frequently involved in karyotypic abnormalities seen in metastatic Merkel cell carcinoma. Cancer Genet. Cytogenet., 67: 65-70, 1993.
13. Schlegelberger, B., Bartels, H., and Sterry, W. Chromosomal evolution in a Merkel cell carcinoma. Cancer Genet. Cytogenet., 75: 74-76, 1994.
14. Gibas, Z., Weil, S., Chen, S. T., and McCue, P. A. Deletion of chromosome arm 1p in a Merkel cell carcinoma (MCC). Genes Chromosomes Cancer, 9: 216-220, 1994.
15. Tope, W. D., and Sangüeza, A. P. Merkel cell carcinoma. Histopathology, immunohistochemistry, and cytogenetic analysis. Dermatol, Surg. Oncol., 20: 648-652, 1994.
16. Larsimont, D., and Verhest, A. Chromosome 6 trisomy as sole anomaly in a primary Merkel cell carcinoma. Virchows Arch., 428: 305-309, 1996.
17. Vasquez-Mazariego, Y., Vallcorba, I., Ferro, M. T., Lopez-Yarto, A., Garcia-Sagredo, J. M., Cabello, P., Resino, M., Munoz, R., Mayayo, M., and San Roman C. Cytogenetic study of neuroendocrine carcinoma of Merkel cells. Cancer Genet. Cytogenet., 92: 79-81, 1996.
18. Ronan, S. G., Green, A. D., Shilkaitis, A., Huang, T. S. W., and Das Gupta, T. K. Merkel cell carcinoma: in vitro and in vivo characteristics of a new cell line. J. Am. Acad. Dermatol., 29: 715-722, 1993.
19. English, K. B., Hammond, E. H., and Stayner, N. Primary culture of cells arising from a neuroendocrine skin carcinoma. Am. J. Dermatol., 12: 589-597, 1990.
20. Moll, I., Bohnert, E., Herbst, C., Förster, W., Moll, R., and Franke, W. W. Establishment and characterization of two Merkel cell tumor cultures. J. Invest. Dermatol., 102: 346-353, 1994.
21. Leonard, J. H., Williams, G., Walters, M. K., Nancarrow, D. J., and Rabbitts, P. H. Deletion mapping of the short arm of chromosome 3 in Merkel cell carcinoma. Genes Chromosomes Cancer 15: 102-107, 1996.
22. Leonard, J. H., Hayward, N. Loss of heterozygosity of chromosome 13 in Merkel cell carcinoma. Genes Chromosomes Cancer, 20: 43-97, 1997.
23. Leonard, J. H., Bell, J. R., and Kearsley, J. H. Characterisation of cell lines established from Merkel cell (small cell) cancer of the skin. Int. J. Cancer, 55: 803-810, 1993.
24. Leonard, J. H., Dash, P., Holland, P., Kearsley, J. H., and Bell, J. R. Characterization of four Merkel cell carcinoma adherent cell lines. Int. J. Cancer. 60: 100-107, 1994.
25. Van Roy, N., Jauch, A., Van Gele, M., Laureys, G., Versteeg, R., De Paepe, A., Cremer, T., and Speleman, F. Comparative genomic hybridization analysis of human neuroblastomas: detection of distal 1p deletions and further molecular genetic characterization of neuroblastoma cell lines. Cancer Genet. Cytogenet., 97: 135-142, 1997.
26. Sambrook, J., Fritsch, E. F., and Maniatis, T. In N. Ford, C. Nolan, and M. Ferguson (eds.), Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
27. du Manoir, S., Speicher, M. R., Joos, S., Schröck, E., Popp, S., Döhner, H., Kovacs, G., Robert-Nicoud, M., Lichter, P., and Cremer, T. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridisation. Hum. Genet., 90: 590-610, 1993.
28. du Manoir, S., Schröck, E., Bentz, M., Speicher, M. R., Joos, S., Ried, T., Lichter P., and Cremer, T. Quantitative analysis of comparative genomic hybridization. Cytometry, 19: 27-41, 1995.
29. Van Gele, M., Van Roy, N., Jauch, A., Laureys, G., Schelfhout, V., De Potter, C. R., Brock, P., Uyttebroeck, A., Sciot, R., Schuuring, E., Versteeg, R., and Speleman, F. Sensitive and reliable detection of genomic imbalances in human neuroblastomas using comparative genomic hybridization analysis. Eur. J. Cancer, 33: 1979-1982; 1997.
30. Levin, N, A., Brzoska, P., Gupta, N., Minna, J. D., Gray J. W., and Christman M. F. Identification of frequent novel genetic alterations in small cell lung carcinoma. Cancer Res., 54: 5086-5091, 1994.
31. Ried, T., Petersen, I., Holtgreve-Grez, H., Speicher, M. R., Schröck, E., du Manoir, S., and Cremer, T. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res., 54: 1801-1806, 1994.
32. Levin, N. A., Brzoska, P. M., Warnock, M. L., Gray, J. W., and Christman, M. F. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes Chromosomes Cancer, 13: 175-185, 1995.
33. Petersen, I., Langreck, H., Wolf, G., Schwendel, A., Psille, R., Vogt, P., Reichel M. B., Ried, T., and Dietel, M. Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br. J. Cancer, 75: 79-86, 1997.
34. Ransom, D. T., Leonard, J. H., Kearsley, J. H., Turbett, G. R., Heel, K., Sosars, V., Hayward, N. K., and Bishop, J. F. Loss of heterozygosity studies in squamous cell carcinomas of the head and neck. Head Neck, 18: 248-253, 1996.
35. Brzoska, P. M., Levin, N. A., Fu, K. K., Kaplan, M. J., Singer, M. I., Gray, J. W, and Christman, M. F. Frequent novel DNA copy number increase in squamous cell head and neck tumors. Cancer Res., 55: 3055-3059, 1995.
36. Speicher, M. R., Howe, C., Crotty, P., du Manoir, S., Costa, J., and Ward, D. C. Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res., 55: 1010-1013, 1995.
37. Bell, D. W., and Testa, J. R. Chromosomes in lung cancer. In: S. R. Wolman and S. Sell (eds.), Human Cytogenetic Cancer Markers, pp. 247-255. Totowa, NJ Humana Press Inc., 1997.
38. Van Dyke, D. L., Worsham, M. J., Benninger, M. S., Krause, C. J., Baker, S. R., Wolf, G. T., Drumheller, T., Tilley, B. C., Carey, T. E. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes Chromosomes Cancer, 9: 192-206, 1994.
39. Mitelman, F., Mertens, F., and Johansson, B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat. Genet., 15: 417-474, 1997.
40. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhou, F., Li, H., Wei, M. H., Chen, F., Glenn, G., Choyko, P., McClellan, M. W., Weng, Y., Duan, D. R., Dean, M., Glavac, D., Richards, F. M., Crossey, P. A., Ferguson-Smith, M. A., Le Paslier, D., Chumakov, I., Cohen, D., Chinault, A. C. Maher, E. R., Linehan, W. M., Zbar, B., and Lerman, M. I. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (Washington DC), 260: 1317-1320, 1993.
41. Van Hengel, J., Nollet, F., Berx, G., Van Roy, N., Speleman, F., and Van Roy, F. Assignment of the human beta-catenin gene (CTNNB1) to 3p22-3p21.3 by fluorescence in situ hybridisation. Cytogenet. Cell Genet., 70: 68-70, 1995.
42. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The human FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated translocation breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
43. Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Tornielli, S., Pilotti, S., De Gregorio, L., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., and Croce, C. M. The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell, 85: 1-20, 1996.
44. Sozzi, G., Alder, H., Tornielli, S., Corletto, V., Baffa, R., Veronese, M. L., Negrini, M., Pilotti, S., Pierotti, M. A., Huebner, K., and Croce, C. M. Aberrant FHIT transcripts in Merkel cell carcinoma. Cancer Res., 56: 2472-2472, 1996.
45. Trybus, T. M., Burgress, A. C., Wojno K. J., Glover, T. W., and Macoska, J. A. Distinct areas of allelic loss on chromosomal region 10p and 10q in human prostate cancer. Cancer Res., 56: 2263-2267, 1996.
46. Morita, R., Susumu, S., Ishikawa, J., Ogawa, O., Yoshida, O., Yamakawa, K., and Nakamura, Y. Common regions of deletion on chromosomes 5q, 6q. and 10q in renal cell carcinoma. Cancer Res., 51: 5817-5820, 1991.
47. Peiffer, S. L., Herzog, T. J., Tribune, D. J., Mutch, D. G., Gersell, D. J., Goodfellow P. J. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res., 55: 1922-1926, 1995.
48. Herbst, R. A., Weiss, J., Ehnis, A., Cavanee, W. K., and Arden, K. C. Loss of heterozygosity for 10q22-qter in malignant melanoma progression. Cancer Res., 54: 3111-3114, 1994.
49. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H. F., and Tavtigian, S. V. Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
50. Marsh, D. J., Zheng, Z., Zedenius, J., Kremeer, H., Padberg, G. W., Larsson, C., Longy, M., and Eng, C. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinoma. Cancer Res., 57: 500-503, 1997.
51. Bova, G. S., Carter, B. S., Bussemakers, M. J., Emi, M., Fujiwara, Y., Kyprianou, N., Jacobs, S. C., Robinson, J. C., Epstein, J. I., and Walsh, P. C. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res., 53: 3869-3873, 1993.
52. Kallioniemi, A., Kallioniemi, O. P., Citro, G., Sauter, G., DeVries, S., Kerschmann, R., Caroll, P., and Waldman, F. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer, 12: 213-219, 1995.
53. Moch, H., Presti, J. C., Sauter, G., Buchholz, N., Jordan, P., Mihatsch, M. J., and Waldman, F. M. Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res., 56: 27-30, 1996.
54. Fujiwara, Y., Emi, M., Ohata, H., Kato, Y., Nakajima, T., Mori, T., and Nakamura, Y. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Cancer Res., 53: 1172-1174, 1993.
55. Marchio, A., Meddeb, M., Pineau, P., Danglot, G., Tiollais, P., Bernheim, A., and Dejean, A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer, 18: 59-65, 1997.
56. Chuaqui, R. F., Sanz-Ortega, J., Vocke, C., Linehan, W. M., Sanz-Esponera, J., Zhuang, Z., Emmert-Buck, M. R., and Merino, M. J. Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas. Cancer Res., 55: 4995-4998, 1995.
57. Yaremko, M. L., Kutza, C. Lysak, J., Mick, R., Recant, W. M., and Westbrook, C. A. Loss of heterozygosity from the short arm of chromosome 8 is associated with invasive behavior in breast cancer. Genes Chromosomes Cancer, 16: 189-195, 1996.
58. Schwab, M., Alitalo, K., Klempnauer, K. H., Varmus, H. E., Bishop, J. M., Gilbert, F., Brodeur, G., Goldstein, M., and Trent, J. M. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature (Lond.), 305: 245-248, 1983.
59. Versteeg, R., Caron, H., Cheng, N. C., van der Drift, P., Slater, R., Westerveld, A., Voute, P. A., Delattre, O., Laureys, G., Van Roy, N., and Speleman, F. Ip36: Every subband a suppressor? Eur. J. Cancer, 31A: 538-541, 1995.
60. Weber, R. G., Sabel, M., Reifenberger J., Sommer, C., Oberstraβ, J., Reifenberger, G., Kiessling, M., and Cremer, T. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization. Oncogene, 13: 983-994, 1996.
61. Rousseau-Merck, M. F., Pizon, V., Tavitian, A., and Berger, R. Chromosome mapping of the human RAS-related RAP1A, RAP1B, and RAP2 genes to chromosomes 1p12→p13, 12q14, and 13q34. respectively. Cytogenet. Cell Genet., 53: 2-4, 1990.
62. Harle, M., Arens, N., Moll, I., Back, W., Schulz, T., and Scherthan, H. Comparative genomic hybridization (CGH) discloses chromosomal and subchromosomal copy number changes in Merkel cell carcinomas. J. Cutan. Pathol., 23: 391-397, 1996.
63. Speicher, M. R., Prescher, G., du Manoir, S., Jauch, A., Horsthemke, B., Bornfeld, N., Becher, R., and Cremer, T. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res., 54: 3817-3823, 1994.
64. Cher, M. L., MacGrogan, D., Bookstein, R., Brown, J. A., Jenkins, R. B., and Jensen R. H. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer, 11: 153-162, 1994.
65. Joos, S., Bergerheim, U. S. R., Pan, Y., Matsuyama, H., Bentz, M., du Manoir, S., and Lichter, P. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer, 14: 267-276, 1995.
66. Visakorpi, T., Kallioniemi, A. H., Syvänen, A-C., Hyytinen, E. R., Karhu, R., Tammela, T., Isola, J. J., and Kallioniemi, O-P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res., 55: 342-347, 1995.
67. Royds, J. A., Sharrard, R. M., Parsons, M. A., Lawry, J., Rees, R., Cottam, D., Wagner, B., and Rennie, I. G. c-myc oncogene expression in ocular melanomas. Graefe's Arch. Clin. Exp. Ophthalmol., 230: 366-371, 1992.
68. So, C. W., Caldas, C., Liu, M. M., Chen, S. J., Huang, Q. H., Gu, L. J., Sham, M. H., and Wiedemann, L. M. EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukemia. Proc. Natl. Acad. Sci. USA, 94: 2563-2568, 1997.